Evaluation of the treatment efficacy of generic enrofloxacin compared to pioneer for first treatment of naturally occurring bovine respiratory disease in a commercial feedlot

Authors

  • M. Theurer Veterinary Research and Consulting Services, LLC, Hays, KS 67601
  • T. Fox Veterinary Research and Consulting Services, LLC, Hays, KS 67601
  • J. Newberry Virbac Corporation, Westlake, TX 76262
  • F. Payot Virbac Corporation, Westlake, TX 76262

DOI:

https://doi.org/10.21423/aabppro20238940

Abstract

The primary objective of this study was to compare the treat­ment efficacy of generic enrofloxacin (Tenotryl™ [enrofloxa­cin] injectable solution; TEN) to pioneer enrofloxacin (Baytril® 100; BAY) for first treatment of naturally occurring bovine respiratory disease (BRD) in a commercial feedlot.

Downloads

Published

2024-05-10

Issue

No. 56 (2023): 2023 Annual Conference Proceedings

Section

Research Summaries